Feed ORMP
OR
Oramed Pharmaceuticals Inc.
ORMP · NASDAQ
$4.30 +0.00% (+$0.00)
1M +2.87%
Market Cap $176.0M
P/E Ratio 1.45x
Div. Yield 5.81%
ROE 60.96%
Bulios Fair Price
$6.42
49.3% upside
Preț actual
$4.3
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile ORMP sunt în prezent subevaluate față de prețul lor de piață. Cum funcționează?
Valuation
100 /100
Cheap P/E 1.45x
P/B 0.74x
EV/EBITDA N/A
Growth
17 /100
Declining Rev. growth 9.55%
Book val. growth 9.58%
EPS growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
45 /100
Average ROIC 5.07%
ROE 60.96%
ROA 45.11%
Debt
69 /100
Low Debt/Equity 0.00x
Current ratio 6.45x
Int. coverage -0.33x
Stability
27 /100
Unstable Beta 1.20x
EPS volatility 433.26%
Profitable years 1
Întreabă StockBot despre ORMP
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Nadav Kidron
Employees
13
Headquarters
New York City
Evenimente viitoare
13 AUG.
Earnings
Upcoming earnings report